Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats
Erin M. Rock, Cheryl L. Limebeer, Gavin N. Petrie, et al.
Psychopharmacology (2017) Vol. 234, Iss. 14, pp. 2207-2217
Closed Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Practical considerations in medical cannabis administration and dosing
Caroline A. MacCallum, Ethan B. Russo
European Journal of Internal Medicine (2018) Vol. 49, pp. 12-19
Closed Access | Times Cited: 555
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
Danilo De Gregorio, Ryan J. McLaughlin, Luca Posa, et al.
Pain (2018) Vol. 160, Iss. 1, pp. 136-150
Open Access | Times Cited: 314
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
Gaurav Bedse, Rebecca J. Bluett, Toni A. Patrick, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 105
Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
Philippe A. Melas, María Scherma, Walter Fratta, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1863-1863
Open Access | Times Cited: 98
Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome
Lyndsey L. Anderson, Ivan K. Low, Samuel D. Banister, et al.
Journal of Natural Products (2019) Vol. 82, Iss. 11, pp. 3047-3055
Open Access | Times Cited: 95
Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
Lara Sharpe, Justin Sinclair, Andrew Kramer, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 91
Opportunities for cannabis in supportive care in cancer
Amber S. Kleckner, Ian R. Kleckner, Charles Kamen, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 82
Constituents of Cannabis Sativa
Erin M. Rock, Linda A. Parker
Advances in experimental medicine and biology (2020), pp. 1-13
Closed Access | Times Cited: 79
Endocannabinoids, cannabinoids and the regulation of anxiety
Gavin N. Petrie, Andrei S. Nastase, Robert J. Aukema, et al.
Neuropharmacology (2021) Vol. 195, pp. 108626-108626
Closed Access | Times Cited: 59
Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
Ahmed Hasbi, Bertha K. Madras, Susan R. George
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 325-325
Open Access | Times Cited: 38
Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy
Lyndsey L. Anderson, Marika Heblinski, Nathan L. Absalom, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 24, pp. 4826-4841
Open Access | Times Cited: 45
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 28
Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5‐HT1A receptor‐mediated suppression of nausea and anxiety in rats
Roger G. Pertwee, Erin M. Rock, Kelsey G. Guenther, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 1, pp. 100-112
Open Access | Times Cited: 59
Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism
Jerzy Zieba, Duncan Sinclair, Terri Sebree, et al.
Pharmacology Biochemistry and Behavior (2019) Vol. 181, pp. 93-100
Closed Access | Times Cited: 51
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids
Rafael Franco, Rafael Rivas‐Santisteban, Irene Reyes‐Resina, et al.
Pharmacological Research (2020) Vol. 158, pp. 104801-104801
Closed Access | Times Cited: 40
Citalopram and Cannabidiol
Lyndsey L. Anderson, Peter T. Doohan, Lachlan Oldfield, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 5, pp. 525-533
Closed Access | Times Cited: 40
Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations
Lyndsey L. Anderson, Maia G. Etchart, Dilara Bahceci, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 40
Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis
C. Kwee, N.A. Leen, Rian C. Van der Kamp, et al.
European Neuropsychopharmacology (2023) Vol. 72, pp. 79-94
Open Access | Times Cited: 16
Decreased sensitivity in adolescent versus adult rats to the antidepressant-like effects of cannabidiol
Cristian Bis‐Humbert, Rubén García‐Cabrerizo, M. Julia García‐Fuster
Psychopharmacology (2020) Vol. 237, Iss. 6, pp. 1621-1631
Closed Access | Times Cited: 36
Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice
Neda Assareh, Anand Gururajan, Cilla Zhou, et al.
Behavioural Pharmacology (2020) Vol. 31, Iss. 6, pp. 591-596
Closed Access | Times Cited: 33
Cannabidiol abrogates cue-induced anxiety associated with normalization of mitochondria-specific transcripts and linoleic acid in the nucleus accumbens shell
Jacqueline‐Marie N. Ferland, Alexandra Chisholm, Jasmina Abdalla, et al.
Molecular Psychiatry (2025)
Closed Access
Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry
Gioacchino Calapai, Carmen Mannucci, İoanna Chinou, et al.
Evidence-based Complementary and Alternative Medicine (2019) Vol. 2019, pp. 1-11
Open Access | Times Cited: 31
Cannabinoids, interoception, and anxiety
Allyson K. Andrade, Briana Renda, Jennifer E. Murray
Pharmacology Biochemistry and Behavior (2019) Vol. 180, pp. 60-73
Closed Access | Times Cited: 30
The interaction effect of sleep deprivation and cannabinoid type 1 receptor in the CA1 hippocampal region on passive avoidance memory, depressive-like behavior and locomotor activity in rats
Maede Rezaie, Mohammad Nasehi, Salar Vaseghi, et al.
Behavioural Brain Research (2020) Vol. 396, pp. 112901-112901
Closed Access | Times Cited: 30
Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments
Marco Mori, Erika Meyer, Francielly F. da Silva, et al.
European Journal of Neuroscience (2021) Vol. 53, Iss. 6, pp. 1738-1751
Closed Access | Times Cited: 25
Page 1 - Next Page

Scroll to top